[HTML][HTML] The Safety and Efficacy of New DIVA Inactivated Vaccines Against Lumpy Skin Disease in Calves

GF Ronchi, M Iorio, A Serroni, M Caporale, L Testa… - Vaccines, 2024 - pmc.ncbi.nlm.nih.gov
Background: Lumpy skin disease virus (Poxviridae family—Capripoxvirus genus) is the
aetiological agent of LSD, a disease primarily transmitted by hematophagous biting …

[PDF][PDF] Development of ELISA techniques for haemorrhagic septicaemia

S Kharb - International Journal of Bioassays, 2015 - researchgate.net
Haemorrhagic septicaemia (HS) caused by Pasteurella multocida serotypes B: 2 and E: 2 in
Asian and African countries respectively is a major epizootic disease of cattle and buffaloes …

Efficacy of bacteriophage Lysed Pasteurella marker vaccine in laboratory animal models with a novel DIVA for haemorrhagic septicaemia

S Qureshi, HM Saxena - Saudi Journal of Biological Sciences, 2019 - Elsevier
Objective The present study aimed at evaluating the efficacy of an improved phage lysate
marker vaccine for haemorrhagic septicaemia in mice and rabbit model and development of …

Immunogenicity of Recombinant HS ABA392 DNA Vaccine Against Haemorrhagic Septicaemia In Animal Model

S Chelliah - 2018 - search.proquest.com
Pasteurella multocida is the main cause of haemorrhagic septicaemia (HS) outbreak in
livestock, such as cattle and buffaloes. This disease is caused by P. multocida serotype B …

Immunogenicity of recombinant HS ABA392 DNA vaccine against Haemorrhagic septicaemia in animal model/Shamini Chelliah

C Shamini - 2018 - studentsrepo.um.edu.my
Pasteurella multocida is the main cause of haemorrhagic septicaemia (HS) outbreak in
livestock, such as cattle and buffaloes. This disease is caused by P. multocida serotype B …

[引用][C] Immunogenicity of recombinant HS ABA392 DNA vaccine against Haemorrhagic septicaemia in animal model

C Shamini, P CHELLIAH - Shamini Chelliah (Doctoral dissertation, University of …